US: 1.646.568.9797 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
Addison disease occurs due to the injury of the adrenal cortex which causes insufficient generation of the hormone aldosterone and cortisol.Indications of Addison's disease are known as primary adrenal insufficiency, resulting from insufficient production of two hormones cortisol and aldosterone. Treatment options for Addison's disease include many medications, usually in the form of tablets, depending on the specific hormones that the body is missing. The drugs required to effectively treat Addison's depends on the hormones that are no longer being effectively produced in the adrenal glands. The global Addison Disease Testing market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Addison Disease Testing volume and value at global level, regional level and company level. From a global perspective, this report represents overall Addison Disease Testing market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report. The following manufacturers are covered: NHS.UK Mayo Clinic VCA Animal Hospital NIDDK Cleveland Clinic WebMD BMJ Best Practice National Organization for Rare Disorders Core Diagnostics Private Limited Laboratory Corporation of America Holdings Sonora Quest Laboratories Segment by Regions North America Europe China Japan Segment by Type Laboratory testing Imaging studies Segment by Application Clinics Hospitals Diagnostics laboratories
Table of Contents Executive Summary 1 Addison Disease Testing Market Overview 1.1 Product Overview and Scope of Addison Disease Testing 1.2 Addison Disease Testing Segment by Type 1.2.1 Global Addison Disease Testing Production Growth Rate Comparison by Type (2014-2025) 1.2.2 Laboratory testing 1.2.3 Imaging studies 1.3 Addison Disease Testing Segment by Application 1.3.1 Addison Disease Testing Consumption Comparison by Application (2014-2025) 1.3.2 Clinics 1.3.3 Hospitals 1.3.4 Diagnostics laboratories 1.4 Global Addison Disease Testing Market by Region 1.4.1 Global Addison Disease Testing Market Size Region 1.4.2 North America Status and Prospect (2014-2025) 1.4.3 Europe Status and Prospect (2014-2025) 1.4.4 China Status and Prospect (2014-2025) 1.4.5 Japan Status and Prospect (2014-2025) 1.5 Global Addison Disease Testing Market Size 1.5.1 Global Addison Disease Testing Revenue (2014-2025) 1.5.2 Global Addison Disease Testing Production (2014-2025) 2 Global Addison Disease Testing Market Competition by Manufacturers 2.1 Global Addison Disease Testing Production Market Share by Manufacturers (2014-2019) 2.2 Global Addison Disease Testing Revenue Share by Manufacturers (2014-2019) 2.3 Global Addison Disease Testing Average Price by Manufacturers (2014-2019) 2.4 Manufacturers Addison Disease Testing Production Sites, Area Served, Product Types 2.5 Addison Disease Testing Market Competitive Situation and Trends 2.5.1 Addison Disease Testing Market Concentration Rate 2.5.2 Addison Disease Testing Market Share of Top 3 and Top 5 Manufacturers 2.5.3 Mergers & Acquisitions, Expansion 3 Global Addison Disease Testing Production Market Share by Regions 3.1 Global Addison Disease Testing Production Market Share by Regions 3.2 Global Addison Disease Testing Revenue Market Share by Regions (2014-2019) 3.3 Global Addison Disease Testing Production, Revenue, Price and Gross Margin (2014-2019) 3.4 North America Addison Disease Testing Production 3.4.1 North America Addison Disease Testing Production Growth Rate (2014-2019) 3.4.2 North America Addison ... | read more...